Top compounds associated with response to RAP2C


Feature Type Standardized
Nominal ANOVA
mRNA ML258 CTRPv2 pan-cancer AAC -0.12 0.002
mRNA Imatinib GDSC1000 pan-cancer AAC -0.18 0.002
mRNA semagacestat CTRPv2 pan-cancer AAC -0.12 0.002
mRNA temsirolimus GDSC1000 pan-cancer AAC 0.11 0.002
mRNA alisertib:navitoclax (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA OSI-906 CTRPv2 pan-cancer AAC -0.11 0.002
mRNA 17-AAG GDSC1000 pan-cancer AAC 0.1 0.002
mRNA decitabine CTRPv2 pan-cancer AAC -0.086 0.002
mRNA tretinoin:carboplatin (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.11 0.002
mRNA tacedinaline CTRPv2 pan-cancer AAC -0.12 0.003
Download CSV